Search ARM

Cellino, an early-stage biotech start-up, is the first to offer single-cell precision to the regenerative medicine industry. Cellino’s platform technology combines stem cell biology, image-based machine learning, and laser processing to develop and manufacture iPSC-derived cells and tissues with single-cell control. This automated, human-free process provides an end-to-end solution for the cell therapy industry.

Contact Cellino
Visit Website